| CAD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | (0.0) | (0.0) | (0.0) | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 1.6 | 2.8 | 3.2 | 5.2 | 8.7 | 6.5 | −25.5% | |
| Selling & marketing | 0.1 | 0.4 | 0.5 | 3.6 | 6.1 | 0.0 | −100.0% | |
| Operating expenses | 1.6 | 2.8 | 3.4 | 5.2 | 8.7 | 15.5 | +77.6% | |
| Operating income | (1.6) | (2.8) | (2.1) | (5.2) | (8.7) | (15.5) | −77.6% | |
| Interest expense | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | — | |
| Interest income | 0.0 | 0.0 | 0.4 | 1.1 | 0.0 | 2.2 | +4409.3% | |
| Other income / expense | (0.0) | (0.1) | 1.8 | 2.1 | 5.8 | (0.3) | −105.5% | |
| Pre-tax income | (1.6) | (2.9) | (0.0) | (3.2) | (2.9) | (15.8) | −447.3% | |
| Income tax | 0.0 | 0.0 | 0.0 | (0.2) | (1.0) | (1.2) | −17.9% | |
| Net income | (1.6) | (2.9) | (1.2) | (3.0) | (1.1) | (14.6) | −1272.9% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.03) | (0.05) | (0.01) | (0.02) | (0.01) | (0.13) | −1200.0% | |
| EPS, diluted (per share) | (0.03) | (0.05) | (0.01) | (0.02) | (0.01) | (0.13) | −1200.0% | |
| EBITDA | (1.6) | (2.8) | (4.9) | (3.3) | (8.7) | (15.3) | −75.5% | |
| Depreciation & amortization | 0.1 | 0.0 | 0.0 | 1.9 | 0.0 | 0.0 | — | |
| Weighted average shares (shares) | 27,064,000 | 53,520,200 | 91,252,400 | 107,053,800 | 107,093,800 | 110,848,396 | +3.5% | |
| Weighted average diluted shares (shares) | 27,064,000 | 53,520,200 | 91,252,400 | 107,053,800 | 107,054,000 | 110,848,396 | +3.5% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
Statements are reported in CAD; the shares trade in GBP.
